Hims & Hers to provide at-home blood testing with new acquisition
Hims & Hers’ share price shot up more than 15% after the company announced it had acquired at-home lab testing facility Trybe Labs.
Hims & Hers, an online pharmacy best known for selling knock-off versions of weight-loss drugs made by Novo Nordisk, will now be able to support at-home blood draws to test “hormone levels, cardiac risk, stress markers, cholesterol, liver function, thyroid function, and prostate health,” the company said in a statement.
Trybe Labs sends customers a packet that includes a blood lancet, similar to those used by diabetics. Consumers then ship the samples back and wait for results.
Hims & Hers didn’t disclose how much it paid to buy Trybe Labs. The company has been on a spending spree recently: it bought an ad for the Super Bowl this month, which sparked pushback from Novo Nordisk and lawmakers, who said it made false or misleading statements about the safety and efficacy of compounded drugs.
Hims & Hers said it will use de-identified blood-testing data to develop a proprietary AI-powered system that gives patients “personalized care.”
Trybe Labs sends customers a packet that includes a blood lancet, similar to those used by diabetics. Consumers then ship the samples back and wait for results.
Hims & Hers didn’t disclose how much it paid to buy Trybe Labs. The company has been on a spending spree recently: it bought an ad for the Super Bowl this month, which sparked pushback from Novo Nordisk and lawmakers, who said it made false or misleading statements about the safety and efficacy of compounded drugs.
Hims & Hers said it will use de-identified blood-testing data to develop a proprietary AI-powered system that gives patients “personalized care.”
